Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

89 studies match

clinicaltrialsPublishedShowing 1–50 of 89 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06833073	A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)	recruiting	Phase 2	308	Merck Sharp & Dohme LLCINDUSTRY	19	Sep 28, 2026	clinicaltrials
NCT05139017	A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)	recruiting	Phase 2 / Phase 3	290	Merck Sharp & Dohme LLCINDUSTRY	26	Sep 25, 2026